Enfermedad pulmonar obstructiva crónica. Actualización 2014
Chronic obstructive pulmonary disease (COPD) is a major public health problem because of its high prevalence (10% in Spain), raising incidence (the World Health Organization predicts that it will be the third cause of death in the world by the year 2020) and high associated socio-economic cost. Over...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | español |
| Publicado: |
2014
|
| Materias: | |
| Acceso en línea: | https://dialnet.unirioja.es/servlet/oaiart?codigo=4968018 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Chronic obstructive pulmonary disease (COPD) is a major public health problem because of its high prevalence (10% in Spain),
raising incidence (the World Health Organization predicts that it will be the third cause of death in the world by the year 2020) and
high associated socio-economic cost. Over the last few years, there have been very significant advances in the understanding and
treatment of COPD, so it is now considered a “preventable and treatable disease”. The following text summarizes the main diagnostic
and therapeutic aspects of this disease according to the last version (2014) of the GOLD (Global Strategy for the Diagnosis,
Management and Prevention of chronic obstructive pulmonary disease) strategy document, which is the global reference for this
disease. In particular, it is of note that the current recommendation for the assessment of COPD is multidimensional. It includes the
assessment of the level of current symptoms, as well as the traditional assessment of airflow limitation severity and the previous
history of exacerbations that can help in predicting the risk of future events. According to these three dimensions, four different
groups of patients can be identified (A, B, C, and D), and specific pharmacological treatment is recommended for each of them. |
|---|